At the time of writing, Resmed Inc [RMD] stock is trading at $247.33, down -0.19%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RMD shares have gain 8.08% over the last week, with a monthly amount glided 7.44%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Piper Sandler started tracking the stock with Neutral rating on January 10, 2025, and set its price target to $252. On December 13, 2024, Stifel initiated with a Hold rating and assigned a price target of $250 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $280 on September 24, 2024. Wolfe Research downgraded its rating to a Underperform but $180 remained the price target by the analyst firm on September 18, 2024. Needham downgraded its rating to Hold for this stock on September 04, 2024. In a note dated June 25, 2024, Oppenheimer downgraded an Perform rating on this stock.
For the past year, the stock price of Resmed Inc fluctuated between $170.56 and $260.49. Currently, Wall Street analysts expect the stock to reach $233.5 within the next 12 months. Resmed Inc [NYSE: RMD] shares were valued at $247.33 at the most recent close of the market. An investor can expect a potential drop of -5.59% based on the average RMD price forecast.
Analyzing the RMD fundamentals
According to Resmed Inc [NYSE:RMD], the company’s sales were 4.81B for trailing twelve months, which represents an 11.08% jump. Gross Profit Margin for this corporation currently stands at 0.57% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.29%, and Net Profit Margin reading is 0.23%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.23 and Total Capital is 0.22. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 245.21 points at the first support level, and at 243.08 for the second support level. However, for the 1st resistance point, the stock is sitting at 249.16, and for the 2nd resistance point, it is at 250.99.
Ratios To Look Out For
It is important to note that Resmed Inc [NYSE:RMD] has a current ratio of 2.92. In addition, the Quick Ratio stands at 1.91 and the Cash Ratio stands at 0.47. Considering the valuation of this stock, the price to sales ratio is 7.55, the price to book ratio is 6.99 and price to earnings (TTM) ratio is 32.79.
Transactions by insiders
Recent insider trading involved Sandercock Brett, Chief Financial Officer, that happened on Jan 08 ’25 when 1000.0 shares were sold. Officer, Sandercock Brett completed a deal on Jan 08 ’25 to buy 1000.0 shares. Meanwhile, Director FARRELL PETER C sold 2000.0 shares on Jan 02 ’25.
